{"disease":{"id":"malignant-brain-tumors","name":"malignant brain tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05622409","title":"A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"National Health Research Institutes, Taiwan","has_results":false},{"nct_id":"NCT02058745","title":"SmartCare: Innovations in Caregiving Interventions","phase":"NA","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT07158710","title":"Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":159,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT05538130","title":"A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":124,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT02798406","title":"Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"DNAtrix, Inc.","has_results":false},{"nct_id":"NCT04171895","title":"Communication Training for Caregivers In Advanced Care Planning","phase":"","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT01505569","title":"Auto Transplant for High Risk or Relapsed Solid or CNS Tumors","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT04396717","title":"Safety Study of Pritumumab in Brain Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Nascent Biotech","has_results":false},{"nct_id":"NCT07438860","title":"Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Tiffany Hodges","has_results":false},{"nct_id":"NCT05798273","title":"(68^Ga)-GaPSMA-11 PET/MR-imaging of Malignant Intra-axial Brain Tumors","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Erasmus Medical Center","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}